Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2001 1
2002 1
2006 2
2007 1
2008 2
2009 5
2010 7
2011 7
2012 3
2013 8
2014 5
2015 5
2016 3
2017 4
2018 3
2019 4
2020 10
2021 12
2022 6
2023 1
2024 4
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

74 results

Results by year

Filters applied: . Clear all
Page 1
Intrinsic and extrinsic factors causing hyperplasia of the prostate.
Kyoda Y, Shibamori K, Shindo T, Maehana T, Hashimoto K, Kobayashi K, Tanaka T, Fukuta F, Masumori N. Kyoda Y, et al. Among authors: fukuta f. Int J Urol. 2024 Jul;31(7):705-717. doi: 10.1111/iju.15446. Epub 2024 Mar 10. Int J Urol. 2024. PMID: 38462732 Free PMC article. Review.
Comparison of Oncological Outcomes of Pembrolizumab as Second-line Therapy and Maintenance Avelumab Therapy in Advanced Urothelial Carcinoma After Platinum-based Chemotherapy.
Shindo T, Hashimoto K, Takahashi A, Miyamoto S, Kunishima Y, Sato S, Fukuta F, Hiyama Y, Takayanagi A, Kato R, Wanifuchi A, Ueki Y, Okada M, Adachi H, Kobayashi KO, Tanaka T, Masumori N; Sapporo Medical University Urologic Oncology Consortium. Shindo T, et al. Among authors: fukuta f. Anticancer Res. 2024 Mar;44(3):1271-1279. doi: 10.21873/anticanres.16922. Anticancer Res. 2024. PMID: 38423657
Traditional Japanese diet and prostate cancer.
Mori M, Masumori N, Fukuta F, Nagata Y, Sonoda T, Sakauchi F, Ohnishi H, Nojima M, Tsukamoto T. Mori M, et al. Among authors: fukuta f. Mol Nutr Food Res. 2009 Feb;53(2):191-200. doi: 10.1002/mnfr.200800285. Mol Nutr Food Res. 2009. PMID: 19101948 Review.
Pre-first-line chemotherapy risk stratification for overall survival in advanced urothelial carcinoma in sequential therapy era.
Shindo T, Hashimoto K, Fujino K, Takahashi A, Hotta H, Maeda T, Kunishima Y, Fukuta F, Ito N, Wanifuchi A, Kato R, Okada M, Matsukawa M, Horita H, Takayanagi A, Kobayashi K, Tanaka T, Masumori N. Shindo T, et al. Among authors: fukuta f. World J Urol. 2024 May 9;42(1):307. doi: 10.1007/s00345-024-04952-z. World J Urol. 2024. PMID: 38722418
Ramucirumab plus docetaxel versus placebo plus docetaxel in patients with locally advanced or metastatic urothelial carcinoma after platinum-based therapy (RANGE): overall survival and updated results of a randomised, double-blind, phase 3 trial.
Petrylak DP, de Wit R, Chi KN, Drakaki A, Sternberg CN, Nishiyama H, Castellano D, Hussain SA, Fléchon A, Bamias A, Yu EY, van der Heijden MS, Matsubara N, Alekseev B, Necchi A, Géczi L, Ou YC, Coskun HS, Su WP, Bedke J, Gakis G, Percent IJ, Lee JL, Tucci M, Semenov A, Laestadius F, Peer A, Tortora G, Safina S, Garcia Del Muro X, Rodriguez-Vida A, Cicin I, Harputluoglu H, Tagawa ST, Vaishampayan U, Aragon-Ching JB, Hamid O, Liepa AM, Wijayawardana S, Russo F, Walgren RA, Zimmermann AH, Hozak RR, Bell-McGuinn KM, Powles T; RANGE study investigators. Petrylak DP, et al. Lancet Oncol. 2020 Jan;21(1):105-120. doi: 10.1016/S1470-2045(19)30668-0. Epub 2019 Nov 18. Lancet Oncol. 2020. PMID: 31753727 Free PMC article. Clinical Trial.
Female urethral hemangioma.
Uchida K, Fukuta F, Ando M, Miyake M. Uchida K, et al. Among authors: fukuta f. J Urol. 2001 Sep;166(3):1008. J Urol. 2001. PMID: 11490280 Review. No abstract available.
Prevention of local symptoms in muscle invasive bladder cancer patients: clinical significance of local radiation therapy.
Okada M, Shindo T, Fujino K, Maeda T, Ito N, Takahashi A, Hotta H, Kunishima Y, Matsukawa M, Takayanagi A, Wanifuchi A, Nofuji S, Kato R, Fukuta F, Hashimoto K, Kobayashi K, Tanaka T, Masumori N. Okada M, et al. Among authors: fukuta f. Support Care Cancer. 2023 Oct 3;31(10):607. doi: 10.1007/s00520-023-08087-6. Support Care Cancer. 2023. PMID: 37787829
74 results